During semaglutide week 1 to 12 , the body is adapting to changes in stomach motility and hunger signaling
Reviewing lifestyle habits Small and realistic changes in nutrition, movement, or sleep often make a noticeable difference
The most frequently reported digestive complaints include nausea (affecting approximately 15-44% of patients depending on dose and indication), vomiting, diarrhea, abdominal pain, and constipation
By promoting weight reduction, semaglutide improves metabolic parameters, including blood pressure, cholesterol levels, and insulin sensitivity, thereby reducing the risk of cardiovascular events
What clinical trial data supports these weight loss numbers